All In MedTech

Device Trial Radar · NCT04713774

Bone Density and Vascular Calcifications Evolution After Renal Transplant

Evolution of Bone Density, Bone Micro-architecture and Vascular Calcifications in Patients After Kidney Transplantation

Last checked: Nov 19, 2026Latest source record: Dec 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Sep 1, 2020

Primary completion

Dec 12, 2025

Study completion Dec 13, 2026

Sponsor

Lead sponsor
University of LiegeAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 19, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

The investigators project is based on: * Assessment of bone architecture by high resolution peripheral scanner (HRpQCT) and bone densitometry (DEXA); * The non-invasive detection of vascular calcifications (by abdominal CT scanner) and bone abnormalities associated with kidney transplantation, as well as the analysis of evolution over time; * Longitudinal evaluation of nephrological clinical parameters (glomerular filtration rate, number and type of rejections, immunosuppressive medications) as well as biological and urinary parameters of mineral metabolism (parathormone, sclerostin, bone alkaline phosphatase) depending on the type and severity of bone abnormalities; * The evaluation of these nephrological clinical parameters and of the biological parameters of mineral metabolism depending on the extent and evolution of vascular calcifications but also on bone morphology; * The study of possible relationships between bone mass and muscle mass (and functioning)

Conditions

  • Kidney Transplant; Complications
  • Bone Loss

Interventions

  • High-resolution peripheral quantitative CT scanner (HRpQCT)Device

    HR-pQCT images of the distal radius and distal tibia (non-dominant, non-fractured limb) will be obtained using the XtremeCT device with standard protocols. HR-pQCT images wil be analysed with standard software and extended cortical measures software. This software identifies the periosteal and endosteal boundaries, enabling assessment of cortical micro- structural bone properties, including apparent cortical thickness (Ct.Th, mm), cortical tissue mineral density (TMD, mgHA/cm3) and cortical porosity (Ct.Po, %).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Bone density evolutionTime frame: At 1 year
  2. Bone density evolutionTime frame: At 2 year
  3. Bone micro-architecture evolutionTime frame: At 1 year

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centre Hospitalier Universitaire de Liège

    Liège, Belgium · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.